-
1
-
-
84862664371
-
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
-
European Association for the Study of the Liver
-
European Association for the Study of the Liver EASL Clinical Practice Guidelines: management of chronic hepatitis B J Hepatol 57 2012 167 185
-
(2012)
J Hepatol
, vol.57
, pp. 167-185
-
-
-
2
-
-
70349240414
-
Chronic hepatitis B: Update 2009
-
A.S. Lok, and B.J. McMahon Chronic hepatitis B: update 2009 Hepatology 50 2009 661 662
-
(2009)
Hepatology
, vol.50
, pp. 661-662
-
-
Lok, A.S.1
McMahon, B.J.2
-
3
-
-
79958038529
-
Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: A meta-analysis of controlled clinical trials
-
W.C. Li, M.R. Wang, L.B. Kong, W.G. Ren, Y.G. Zhang, and Y.M. Nan Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials BMC Infect Dis 11 2011 165
-
(2011)
BMC Infect Dis
, vol.11
, pp. 165
-
-
Li, W.C.1
Wang, M.R.2
Kong, L.B.3
Ren, W.G.4
Zhang, Y.G.5
Nan, Y.M.6
-
4
-
-
67349168493
-
High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: A long-term follow-up study
-
R. Moucari, A. Korevaar, O. Lada, M. Martinot-Peignoux, N. Boyer, and V. Mackiewicz High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study J Hepatol 50 2009 1084 1092
-
(2009)
J Hepatol
, vol.50
, pp. 1084-1092
-
-
Moucari, R.1
Korevaar, A.2
Lada, O.3
Martinot-Peignoux, M.4
Boyer, N.5
MacKiewicz, V.6
-
5
-
-
21244447705
-
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
-
G.K. Lau, T. Piratvisuth, K.X. Luo, P. Marcellin, S. Thongsawat, and G. Cooksley Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B N Engl J Med 352 2005 2682 2695
-
(2005)
N Engl J Med
, vol.352
, pp. 2682-2695
-
-
Lau, G.K.1
Piratvisuth, T.2
Luo, K.X.3
Marcellin, P.4
Thongsawat, S.5
Cooksley, G.6
-
6
-
-
84873726484
-
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: A 5-year open-label follow-up study
-
P. Marcellin, E. Gane, M. Buti, N. Afdhal, W. Sievert, and I.M. Jacobson Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study Lancet 381 2013 468 475
-
(2013)
Lancet
, vol.381
, pp. 468-475
-
-
Marcellin, P.1
Gane, E.2
Buti, M.3
Afdhal, N.4
Sievert, W.5
Jacobson, I.M.6
-
7
-
-
57349095400
-
Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B
-
P. Marcellin, E.J. Heathcote, M. Buti, E. Gane, R.A. de Man, and Z. Krastev Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B N Engl J Med 359 2008 2442 2455
-
(2008)
N Engl J Med
, vol.359
, pp. 2442-2455
-
-
Marcellin, P.1
Heathcote, E.J.2
Buti, M.3
Gane, E.4
De Man, R.A.5
Krastev, Z.6
-
8
-
-
79952227475
-
No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus
-
A. Snow-Lampart, B. Chappell, M. Curtis, Y. Zhu, F. Myrick, and J. Schawalder No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus Hepatology 53 2011 763 773
-
(2011)
Hepatology
, vol.53
, pp. 763-773
-
-
Snow-Lampart, A.1
Chappell, B.2
Curtis, M.3
Zhu, Y.4
Myrick, F.5
Schawalder, J.6
-
9
-
-
75449107726
-
Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B
-
T.T. Chang, C.L. Lai, S. Kew Yoon, S.S. Lee, H.S. Coelho, and F.J. Carrilho Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B Hepatology 51 2010 422 430
-
(2010)
Hepatology
, vol.51
, pp. 422-430
-
-
Chang, T.T.1
Lai, C.L.2
Kew Yoon, S.3
Lee, S.S.4
Coelho, H.S.5
Carrilho, F.J.6
-
10
-
-
84874300734
-
Association of on-treatment serum hepatitis B surface antigen level with sustained virological response to nucleos(t)ide analog in patients with hepatitis B e-antigen positive chronic hepatitis B
-
S.S. Kim, D. Lee, M.H. Lee, J.Y. Cheong, and S.W. Cho Association of on-treatment serum hepatitis B surface antigen level with sustained virological response to nucleos(t)ide analog in patients with hepatitis B e-antigen positive chronic hepatitis B Hepatol Res 43 2013 219 227
-
(2013)
Hepatol Res
, vol.43
, pp. 219-227
-
-
Kim, S.S.1
Lee, D.2
Lee, M.H.3
Cheong, J.Y.4
Cho, S.W.5
-
11
-
-
84890566066
-
Changes of HBsAg and interferon-inducible protein 10 serum levels in naive HBeAg-negative chronic hepatitis B patients under 4-year entecavir therapy
-
G. Papatheodoridis, J. Goulis, S. Manolakopoulos, A. Margariti, X. Exarchos, and G. Kokkonis Changes of HBsAg and interferon-inducible protein 10 serum levels in naive HBeAg-negative chronic hepatitis B patients under 4-year entecavir therapy J Hepatol 60 2014 62 68
-
(2014)
J Hepatol
, vol.60
, pp. 62-68
-
-
Papatheodoridis, G.1
Goulis, J.2
Manolakopoulos, S.3
Margariti, A.4
Exarchos, X.5
Kokkonis, G.6
-
12
-
-
79960124298
-
Serum HBsAg decline during long-term potent nucleos(t)ide analogue therapy for chronic hepatitis B and prediction of HBsAg loss
-
R. Zoutendijk, B.E. Hansen, A.J. van Vuuren, C.A. Boucher, and H.L. Janssen Serum HBsAg decline during long-term potent nucleos(t)ide analogue therapy for chronic hepatitis B and prediction of HBsAg loss J Infect Dis 204 2011 415 418
-
(2011)
J Infect Dis
, vol.204
, pp. 415-418
-
-
Zoutendijk, R.1
Hansen, B.E.2
Van Vuuren, A.J.3
Boucher, C.A.4
Janssen, H.L.5
-
13
-
-
84875279880
-
Hepatitis B surface antigen levels: Association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients
-
P. Marcellin, F. Bonino, C. Yurdaydin, S. Hadziyannis, R. Moucari, and H.P. Kapprell Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients Hepatol Int 7 2013 88 97
-
(2013)
Hepatol Int
, vol.7
, pp. 88-97
-
-
Marcellin, P.1
Bonino, F.2
Yurdaydin, C.3
Hadziyannis, S.4
Moucari, R.5
Kapprell, H.P.6
-
14
-
-
84922773840
-
A finite course of peginterferon alfa-2a results in inactive chronic hepatitis B and HBsAg clearance 5 years post-treatment in patients with HBeAg-negative disease: Baseline characteristics and predictive factors of long-term response
-
October 30-November 3 Boston, MA
-
Marcellin P, Piratvisuth T, Brunetto MR, Bonino F, Farci P, Yurdaydin C, et al. A finite course of peginterferon alfa-2a results in inactive chronic hepatitis B and HBsAg clearance 5 years post-treatment in patients with HBeAg-negative disease: baseline characteristics and predictive factors of long-term response. In: 60th Annual Meeting of the American Association for the Study of Liver Diseases; October 30-November 3, 2009; Boston, MA.
-
(2009)
60th Annual Meeting of the American Association for the Study of Liver Diseases
-
-
Marcellin, P.1
Piratvisuth, T.2
Brunetto, M.R.3
Bonino, F.4
Farci, P.5
Yurdaydin, C.6
-
15
-
-
84856203453
-
Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-alpha2b: Relation to response and HBV genotype
-
M.J. Sonneveld, V. Rijckborst, Y. Cakaloglu, K. Simon, E.J. Heathcote, and F. Tabak Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-alpha2b: relation to response and HBV genotype Antivir Ther 17 2012 9 17
-
(2012)
Antivir Ther
, vol.17
, pp. 9-17
-
-
Sonneveld, M.J.1
Rijckborst, V.2
Cakaloglu, Y.3
Simon, K.4
Heathcote, E.J.5
Tabak, F.6
-
16
-
-
77956592924
-
Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients
-
K. Wursthorn, M. Jung, A. Riva, Z.D. Goodman, P. Lopez, and W. Bao Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients Hepatology 52 2010 1611 1620
-
(2010)
Hepatology
, vol.52
, pp. 1611-1620
-
-
Wursthorn, K.1
Jung, M.2
Riva, A.3
Goodman, Z.D.4
Lopez, P.5
Bao, W.6
-
17
-
-
80055059164
-
Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C
-
Y.F. Liaw, J.D. Jia, H.L. Chan, K.H. Han, T. Tanwandee, and W.L. Chuang Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C Hepatology 54 2011 1591 1599
-
(2011)
Hepatology
, vol.54
, pp. 1591-1599
-
-
Liaw, Y.F.1
Jia, J.D.2
Chan, H.L.3
Han, K.H.4
Tanwandee, T.5
Chuang, W.L.6
-
18
-
-
43149102738
-
Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in the Gambia
-
M.E. Mendy, S.J. McConkey, M.A. van der Sande, S. Crozier, S. Kaye, and D. Jeffries Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia Virol J 5 2008 49
-
(2008)
Virol J
, vol.5
, pp. 49
-
-
Mendy, M.E.1
McConkey, S.J.2
Van Der Sande, M.A.3
Crozier, S.4
Kaye, S.5
Jeffries, D.6
-
19
-
-
0026580185
-
Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B
-
M.A. Loriot, P. Marcellin, E. Bismuth, M. Martinot-Peignoux, N. Boyer, and C. Degott Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B Hepatology 15 1992 32 36
-
(1992)
Hepatology
, vol.15
, pp. 32-36
-
-
Loriot, M.A.1
Marcellin, P.2
Bismuth, E.3
Martinot-Peignoux, M.4
Boyer, N.5
Degott, C.6
-
20
-
-
0025156837
-
Persistence of hepatitis B virus DNA demonstrated by polymerase chain reaction in serum and liver after loss of HBsAg induced by antiviral therapy
-
P. Marcellin, M. Martinot-Peignoux, M.A. Loriot, E. Giostra, N. Boyer, and V. Thiers Persistence of hepatitis B virus DNA demonstrated by polymerase chain reaction in serum and liver after loss of HBsAg induced by antiviral therapy Ann Intern Med 112 1990 227 228
-
(1990)
Ann Intern Med
, vol.112
, pp. 227-228
-
-
Marcellin, P.1
Martinot-Peignoux, M.2
Loriot, M.A.3
Giostra, E.4
Boyer, N.5
Thiers, V.6
-
21
-
-
73449089431
-
Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-alpha2a
-
R. Moucari, M. Martinot-Peignoux, V. Mackiewicz, N. Boyer, M.P. Ripault, and C. Castelnau Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-alpha2a Antivir Ther 14 2009 1183 1188
-
(2009)
Antivir Ther
, vol.14
, pp. 1183-1188
-
-
Moucari, R.1
Martinot-Peignoux, M.2
MacKiewicz, V.3
Boyer, N.4
Ripault, M.P.5
Castelnau, C.6
-
22
-
-
44949180106
-
Understanding the immunopathogenesis of chronic hepatitis B virus: An Asian prospective
-
A.T. Tan, S. Koh, V. Goh, and A. Bertoletti Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospective J Gastroenterol Hepatol 23 2008 833 843
-
(2008)
J Gastroenterol Hepatol
, vol.23
, pp. 833-843
-
-
Tan, A.T.1
Koh, S.2
Goh, V.3
Bertoletti, A.4
-
23
-
-
4544239807
-
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B
-
P. Marcellin, G.K. Lau, F. Bonino, P. Farci, S. Hadziyannis, and R. Jin Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B N Engl J Med 351 2004 1206 1217
-
(2004)
N Engl J Med
, vol.351
, pp. 1206-1217
-
-
Marcellin, P.1
Lau, G.K.2
Bonino, F.3
Farci, P.4
Hadziyannis, S.5
Jin, R.6
-
24
-
-
0025734569
-
Long-term remission of chronic hepatitis B after alpha-interferon therapy
-
J. Korenman, B. Baker, J. Waggoner, J.E. Everhart, A.M. Di Bisceglie, and J.H. Hoofnagle Long-term remission of chronic hepatitis B after alpha-interferon therapy Ann Intern Med 114 1991 629 634
-
(1991)
Ann Intern Med
, vol.114
, pp. 629-634
-
-
Korenman, J.1
Baker, B.2
Waggoner, J.3
Everhart, J.E.4
Di Bisceglie, A.M.5
Hoofnagle, J.H.6
-
25
-
-
72949113706
-
Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naive HBeAg-positive patients with chronic hepatitis B
-
R.G. Gish, T.T. Chang, C.L. Lai, R. de Man, A. Gadano, and F. Poordad Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naive HBeAg-positive patients with chronic hepatitis B J Viral Hepat 17 2010 16 22
-
(2010)
J Viral Hepat
, vol.17
, pp. 16-22
-
-
Gish, R.G.1
Chang, T.T.2
Lai, C.L.3
De Man, R.4
Gadano, A.5
Poordad, F.6
-
26
-
-
48549107919
-
Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b
-
E.H. Buster, H.J. Flink, Y. Cakaloglu, K. Simon, J. Trojan, and F. Tabak Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b Gastroenterology 135 2008 459 467
-
(2008)
Gastroenterology
, vol.135
, pp. 459-467
-
-
Buster, E.H.1
Flink, H.J.2
Cakaloglu, Y.3
Simon, K.4
Trojan, J.5
Tabak, F.6
-
27
-
-
79955093993
-
Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir
-
J.M. Lee, S.H. Ahn, H.S. Kim, H. Park, H.Y. Chang, and Y. Kim Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir Hepatology 53 2011 1486 1493
-
(2011)
Hepatology
, vol.53
, pp. 1486-1493
-
-
Lee, J.M.1
Ahn, S.H.2
Kim, H.S.3
Park, H.4
Chang, H.Y.5
Kim, Y.6
-
28
-
-
65449123444
-
Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients
-
R. Moucari, V. Mackiewicz, O. Lada, M.P. Ripault, C. Castelnau, and M. Martinot-Peignoux Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients Hepatology 49 2009 1151 1157
-
(2009)
Hepatology
, vol.49
, pp. 1151-1157
-
-
Moucari, R.1
MacKiewicz, V.2
Lada, O.3
Ripault, M.P.4
Castelnau, C.5
Martinot-Peignoux, M.6
|